April 23, 2024

• 

[THE INVESTOR] As of Mar. 27 02:40 P.M., LabGen declined 1.57%, compared with yesterday, to 8,800 won (US$7.89). It had declined 17.37% through the past month. Standard deviation, which indicates volatility of stock, records 3% over the same period over one month.

Compared with its close competitors within the same industry, KOSDAQ, the monthly volatility of LabGen was not so high, the earnings rate for 1 month was also the lowest with decline of stock price. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -5.7%. Compared with its peer group. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -1.7, and thus the industrial comparison performance was not so good.

By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.